PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.35%
Revenue growth 1.25-1.5x ADI's 4.78%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
8.67%
Gross profit growth above 1.5x ADI's 3.83%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
19.59%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
19.65%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
20.94%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
22.22%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
22.58%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.03%
Share reduction while ADI is at 0.22%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.10%
Reduced diluted shares while ADI is at 0.17%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.21%
Dividend reduction while ADI stands at 0.04%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
78.45%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
84.17%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
75.81%
10Y revenue/share CAGR above 1.5x ADI's 21.70%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
43.93%
5Y revenue/share CAGR 1.25-1.5x ADI's 37.18%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
9.01%
Positive 3Y CAGR while ADI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
139.61%
10Y OCF/share CAGR above 1.5x ADI's 52.72%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
96.33%
5Y OCF/share CAGR above 1.5x ADI's 48.21%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
31.16%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
139.45%
Net income/share CAGR above 1.5x ADI's 28.24% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
81.78%
5Y net income/share CAGR at 50-75% of ADI's 155.88%. Martin Whitman might see a shortfall in operational efficiency or brand power.
48.33%
Positive short-term CAGR while ADI is negative. John Neff would see a clear advantage in near-term profit trajectory.
32.52%
10Y equity/share CAGR at 50-75% of ADI's 58.99%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
31.35%
Below 50% of ADI's 88.90%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2.49%
Below 50% of ADI's 28.51%. Michael Burry suspects a serious short-term disadvantage in building book value.
1346.20%
10Y dividend/share CAGR above 1.5x ADI's 517.10%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
173.68%
5Y dividend/share CAGR above 1.5x ADI's 84.81%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
132.62%
3Y dividend/share CAGR above 1.5x ADI's 47.63%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-3.27%
Firm’s AR is declining while ADI shows 9.40%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.40%
Inventory shrinking or stable vs. ADI's 39.09%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
0.51%
Asset growth well under 50% of ADI's 36.07%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.09%
75-90% of ADI's 1.31%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-0.06%
We’re deleveraging while ADI stands at 228.71%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.87%
Our R&D shrinks while ADI invests at 2.82%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.91%
We cut SG&A while ADI invests at 30.27%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.